Goldman Sachs’s Covetrus, Inc. Common Stock CVET Stock Holding History

Goldman Sachs’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-15,000	Closed	-$431K	–	6459
2020 Q4	$431K	Hold	15,000	–	–	﹤0.01%	4695
2020 Q3	$366K	Buy	+15,000	New	+$323K	﹤0.01%	4635
2020 Q1	–	Sell	-30,000	Closed	-$396K	–	5657
2019 Q4	$396K	Hold	30,000	–	–	﹤0.01%	4631
2019 Q3	$357K	Buy	+30,000	New	+$555K	﹤0.01%	4610

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Goldman Sachs's CVET Position: Q4 2022 in Review

Goldman Sachs sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 1,794,373 shares — an estimated $37.5M sold.

Goldman Sachs first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $40.3M in Q2 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

Goldman Sachs reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Goldman Sachs sold 1,794,373 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $37.5M.
Goldman Sachs first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
Goldman Sachs's Covetrus, Inc. Common Stock position peaked at $40.3M in Q2 2019.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.